Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery

Free Radical Biology and Medicine

Volumn 24, Issue 7-8, 1998, Pages 1176-1186

  Nakamura, Hajime ^a   Vaage, Jarle ^a   Valen, Guro ^a   Padilla, C Alicia ^a   Björnstedt, Mikael ^a   Holmgren, Arne ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cardiopulmonary bypass; Enzyme linked Immunosorbent assay; Free radicals; Glutaredoxin; Oxidative stress; Reperfusion; Thioredoxin

Indexed keywords

FREE RADICAL; GLUTAREDOXIN; THIOREDOXIN; TRANSFERASE; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ANTIGENICITY; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOGLOBIN DETERMINATION; HEMOLYSIS; HUMAN; IMMUNOBLOTTING; LIPID PEROXIDATION; OPEN HEART SURGERY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION;

EID: 0032078806     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00429-2     Document Type: Article

References (40)

1. Holmgren A. Thioredoxin and glutaredoxin systems. J. Biol. Chem. 264:1989;13963-13966.
2. Martin J. Thioredoxin - A fold for all reasons. Structure. 3:1995;245-250.
3. Blombäck B., Blombäck M., Finkbeiner W., Holmgren A., Kowalska-Loth B., Olovson G. Enzymatic reduction of disulfide bonds in fibrinogen by the thioredoxin system. I. Identification of reduced bonds and studies on reoxidation process. Thromb. Res. 4:1974;55-75.
4. Larsson A., Holmgren A., Bratt I. Thioredoxin and glutathione in cultured fibroblasts from human cases with 5-oxoprolinuria and cystinosis. FEBS Lett. 87:1978;61-64.
5. Tagaya Y., Maeda Y., Mitsui A., Kondo N., Matsui H., Hamuro J., Brown N., Arai K., Yokota T., Wakasugi H., Yodoi J. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; Possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J. 8:1989;757-764.
6. Ericson M. L., Horling J., Wendel H. V., Holmgren A., Rosen A. Secretion of thioredoxin after in vitro activation of human B cells. Lymphokine Cytokine Res. 11:1992;201-207.
7. Rosén A., Lundman P., Carlsson M., Bhavani K., Srinivasa B. R., Kjellström G., Nilsson K., Holmgren A. A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin. Int. Immunol. 7:1995;625-633.
8. Holmgren A., Luthman M. Tissue distribution and subcellular localization of bovine thioredoxin determined by radioimmunoassay. Biochemistry. 17:1978;4071-4077.
9. Nakamura H., DeRosa S., Roederer M., Anderson M. T., Dubs J. G., Yodoi J., Holmgren A., Herzenberg L. A., Herzenberg L. A. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int. Immunol. 8:1996;101-109.
10. Holmgren A. Hydrogen donors system for Escherichia coli ribonucleoside-diphosphate reductase dependent upon glutathione. Proc. Natl. Acad. Sci. USA. 73:1976;2275-2279.
11. Åslund F., Ehn B., Miranda V. A., Pueyo C., Holmgren A. Two additional glutaredoxins exist in Escherichia coli: Glutaredoxin 3 is a hydrogen donor for ribonucleotide reductase in a thioredoxin/glutaredoxin 1 double mutant. Proc. Natl. Acad. Sci. USA. 91:1994;9813-9817.
12. Luthman M., Ericksson S., Holmgren A., Thelander L. Glutathione-dependent hydrogen donor system for calf thymus ribonucleotide diphosphate reductase. Proc. Natl. Acad. Sci. USA. 76:1979;2158-2162.
13. Luthman M., Holmgren A. Glutaredoxin from calf thymus purification to homogeneity. J. Biol. Chem. 257:1982;6686-6690.
14. Wells W. W., Yang Y., Deits T. L., Gan Z.-R. Thioltransferase. Adv. Enzymol. 66:1993;149-201.
15. Padilla C. A., Martínez-Galisteo E., Bárcena J. A., Spyrou G., Holmgren A. Purification from placenta, amino acid sequence, structure comparisons and cDNA cloning of human glutaredoxin. Eur. J. Biochem. 227:1995;27-34.
16. Padilla C. A., Spyrou G., Holmgren A. High-level expression of fully active human glutaredoxin in E. coli and characterization of Cys7 to Ser mutant protein. FEBS Lett. 378:1996;69-73.
17. Björnstedt M., Xue J., Huang W., Åkesson B., Holmgren A. The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. J. Biol. Chem. 269:1994;29382-29384.
18. Edmunds L. H. Blood-surface interactions during cardiopulmonary bypass. J. Cardiac Surg. 8:1993;404-410.
19. Butler J., Rocker G. M., Westaby S. Inflammation response to cardiopulmonary bypass. Ann. Thorac. Surg. 55:1993;552-559.
20. Kirklin J. W., Barratt-Boyes B. G. Hypothermia, circulatory arrest, and cardiopulmonary bypass. Cardiac surgery. 2nd ed. 1993;61-128 Churchill Livingstone, New York.
21. Gutteridge J. M. C., Halliwell B. Reoxigenation injury and antioxidant protection A tale of two paradoxes . Arch. Biochem. Biophys. 283:1990;223-226.
22. Vaage J., Valen G. Could treatment with scavengers of oxygen free radicals minimize complications in cardiac surgery? Klin. Wochenschr. 69:1991;1066-1072.
23. Valen G., Vaage J. Toxic oxygen metabolites and leukocytes in reperfusion injury. Scand. J. Thorac. Cardiovasc. Surg. Suppl. 41:1993;19-30.
24. Kukreja R. C., Hess M. L. Free radicals, cardiovascular dysfunction and protection strategies. 1994;R. G. Landes Company, Austin, TX.
25. Ren X., Björnstedt M., Shen B., Ericson M. L., Holmgren A. Mutagenesis of structural half-cystine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione. Biochemistry. 32:1993;9701-9708.
26. Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ. Res. 47:1980;1-9.
27. Mieyal J. J., Starke D. W., Gravina S. A., Dothey C., Chung J. S. Thioltransferase in human red blood cells Purification and properties . Biochemistry. 30:1991;6088-6097.
28. Matsuda M., Masutani H., Nakamura H., Miyajima S., Yamauchi A., Yonehara S., Uchida A., Irimajiri K., Horiuchi A., Yodoi J. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J. Immunol. 147:1991;3837-3841.
29. Nakamura H., Matsuda M., Furuke K., Kitaoka Y., Iwata S., Toda K., Inamoto T., Yamaoka Y., Ozawa K., Yodoi J. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol. Lett. 42:1994;75-80.
30. Yokomise H., Fukuse T., Hirata T., Ohkubo K.-I., Go T., Muro K., Yagi K., Inui K., Hitomi S., Mitsui A., Hirakawa T., Yodoi J., Wada H. Effect of recombinant human adult T cell leukemia-derived factor on rat lung reperfusion injury. Respiration. 61:1994;99-104.
31. Yagi K., Liu C., Bando T., Yokomise H., Inui K., Hitomi S., Wada H. Inhibition of reperfusion injury by human thioredoxin (adult T-cell leukemia-derived factor) in canine lung transplantation. J. Thorac. Cardiovasc. Surg. 108:1994;913-921.
32. Terada T., Oshida T., Nishimura M., Maeda H., Hara T., Hosomi S., Mizoguchi T., Nishihara T. Study on human erythrocyte thioltransferase Comparative characterization with bovine enzyme and its physiological role under oxidative stress . J. Biochem. 111:1992;688-692.
33. Yoshitake S., Nanri H., Fernando M. R., Minakami S. Posible differences in the regenerative roles played by thioltransferase and thioredoxin for oxidatively damaged proteins. J. Biochem. 116:1994;42-46.
34. Rozell B., Bárcena J. A., Martínez-Galisteo E., Padilla C. A., Holmgren A. Immunochemical characterization and tissue distribution of glutaredoxin (thioltransferase) from calf. Eur. J. Cell. Biol. 62:1993;314-323.
35. Rubartelli A., Bajetto A., Allavena G., Wollman E., Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem. 267:1992;24161-24164.
36. Rubartelli A., Bonifaci N., Sitia R. High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells. Cancer Res. 55:1995;675-680.
37. Valen G., Khoschsorur G. A., Almdahl S. M., Esterbauer H., Vaage J. Lipid peroxidation in open heart surgery. Perfusion. 9:1994;277-283.
38. Semb A. G., Vaage J., Lie M., Sörlie D., Mjös O. D. Leukocytes and cardiopulmonary bypass In vitro production of oxygen free radicals and trapping in the reperfused myocardium . Perfusion. 5:1990;169-180.
39. Semb A. G., Babrielsen T. Ö., Hallstensen T. S., Fagerhol M. K., Brandtzaeg P., Vaage J. Cardiac surgery and distribution of the granulocyte protein L 1. Eur. J. Cardiothorac. Surg. 5:1991;363-367.
40. Valen G., Eriksson E., Risberg B., Vaage J. Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood. Eur. J. Cardiothorac. Surg. 8:1996;324-330.